BG-68501
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BG-68501, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors [Phase 1]